They might get a better response from the market if they focus on the other trials they announced previously that have been radio silent for 6+ months instead of just continuing to throw sheet at the wall... dementia/Alzheimers trial, CBD effects on driving anyone else remember those? I'm sure there's more.
At this point MGC come across as having collective unmedicated ADD and as a symptom they never finish what they started. Maybe they can run a trial on that?
MXC Price at posting:
2.4¢ Sentiment: None Disclosure: Not Held
